Mesalamine Delayed Release Tablets and Von willebrand factor recombinant Intravenous
Determining the interaction of Mesalamine Delayed Release Tablets and Von willebrand factor recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
Generic Name: von willebrand factor
Brand name: Vonvendi, Wilfactin
Synonyms: Von Willebrand factor (recombinant), von Willebrand Factor (Recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mesalamine Delayed Release Tablets-Vonvendi
- Mesalamine Delayed Release Tablets-Vopac
- Mesalamine Delayed Release Tablets-Vopac MDS
- Mesalamine Delayed Release Tablets-Vorapaxar
- Mesalamine Delayed Release Tablets-Vorapaxar Sulfate
- Mesalamine Delayed Release Tablets-Voraxaze
- Von willebrand factor recombinant Intravenous-Mesalamine Long-Acting Capsules (Apriso)
- Von willebrand factor recombinant Intravenous-Mesalamine Long-Acting Capsules (Delzicol)
- Von willebrand factor recombinant Intravenous-Mesalamine Long-Acting Capsules (Pentasa)
- Von willebrand factor recombinant Intravenous-Mesalamine rectal
- Von willebrand factor recombinant Intravenous-Mesalamine Rectal Enema
- Von willebrand factor recombinant Intravenous-Mesalamine Rectal Suspension